Weller M - Search Results

1

Non-IDH1-R132H IDH1/2 mutations are associated with increased DNA methylation and improved survival in astrocytomas, compared to IDH1-R132H mutations.

Tesileanu CMS, Vallentgoed WR, Sanson M, Taal W, Clement PM, Wick W, Brandes AA, Baurain JF, Chinot OL, Wheeler H, Gill S, Griffin M, Rogers L, Rudà R, Weller M, McBain C, Reijneveld J, Enting RH, Caparrotti F, Lesimple T, Clenton S, Gijtenbeek A, Lim E, de Vos F, Mulholland PJ, Taphoorn MJB, de Heer I, Hoogstrate Y, de Wit M, Boggiani L, Venneker S, Oosting J, Bovée JVMG, Erridge S, Vogelbaum MA, Nowak AK, Mason WP, Kros JM, Wesseling P, Aldape K, Jenkins RB, Dubbink HJ, Baumert B, Golfinopoulos V, Gorlia T, van den Bent M, French PJ. Tesileanu CMS, et al. Among authors: weller m. Acta Neuropathol. 2021 Jun;141(6):945-957. doi: 10.1007/s00401-021-02291-6. Epub 2021 Mar 19. Acta Neuropathol. 2021. PMID: 33740099 Free PMC article.

2

BCL-2 promotes migration and invasiveness of human glioma cells.

Wick W, Wagner S, Kerkau S, Dichgans J, Tonn JC, Weller M. Wick W, et al. Among authors: weller m. FEBS Lett. 1998 Dec 4;440(3):419-24. doi: 10.1016/s0014-5793(98)01494-x. FEBS Lett. 1998. PMID: 9872414 Free article.

3

Betulinic acid-induced apoptosis in glioma cells: A sequential requirement for new protein synthesis, formation of reactive oxygen species, and caspase processing.

Wick W, Grimmel C, Wagenknecht B, Dichgans J, Weller M. Wick W, et al. Among authors: weller m. J Pharmacol Exp Ther. 1999 Jun;289(3):1306-12. J Pharmacol Exp Ther. 1999. PMID: 10336521

4

Transforming growth factor-beta and p-21: multiple molecular targets of decorin-mediated suppression of neoplastic growth.

Ständer M, Naumann U, Wick W, Weller M. Ständer M, et al. Among authors: weller m. Cell Tissue Res. 1999 May;296(2):221-7. doi: 10.1007/s004410051283. Cell Tissue Res. 1999. PMID: 10382266 Review.

5

PTEN gene transfer in human malignant glioma: sensitization to irradiation and CD95L-induced apoptosis.

Wick W, Furnari FB, Naumann U, Cavenee WK, Weller M. Wick W, et al. Among authors: weller m. Oncogene. 1999 Jul 8;18(27):3936-43. doi: 10.1038/sj.onc.1202774. Oncogene. 1999. PMID: 10435616

6

Malignant glioma biology: role for TGF-beta in growth, motility, angiogenesis, and immune escape.

Platten M, Wick W, Weller M. Platten M, et al. Among authors: weller m. Microsc Res Tech. 2001 Feb 15;52(4):401-10. doi: 10.1002/1097-0029(20010215)52:4<401::AID-JEMT1025>3.0.CO;2-C. Microsc Res Tech. 2001. PMID: 11170299 Review.

7

Treosulfan chemotherapy for recurrent malignant glioma.

Schmidt F, Wick W, Herrlinger U, Dichgans J, Weller M. Schmidt F, et al. Among authors: weller m. J Neurooncol. 2000 Sep;49(3):231-4. doi: 10.1023/a:1006496831144. J Neurooncol. 2000. PMID: 11212902 Clinical Trial.

8

Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma.

Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W. Wild-Bode C, et al. Among authors: weller m. Cancer Res. 2001 Mar 15;61(6):2744-50. Cancer Res. 2001. PMID: 11289157

9

N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibits transforming growth factor-beta relesase and reduces migration and invasiveness of human malignant glioma cells.

Platten M, Wild-Bode C, Wick W, Leitlein J, Dichgans J, Weller M. Platten M, et al. Among authors: weller m. Int J Cancer. 2001 Jul 1;93(1):53-61. doi: 10.1002/ijc.1289. Int J Cancer. 2001. PMID: 11391621 Free article.

10

Molecular determinants of glioma cell migration and invasion.

Wild-Bode C, Weller M, Wick W. Wild-Bode C, et al. Among authors: weller m. J Neurosurg. 2001 Jun;94(6):978-84. doi: 10.3171/jns.2001.94.6.0978. J Neurosurg. 2001. PMID: 11409528

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,663 results

Search Page